Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Amendment No. 14) (Jersey) Order 2017

Made                                                                        6th October 2017

Coming into force                                                   13th October 2017

THE MINISTER FOR SOCIAL SECURITY, in pursuance of Articles 15, 17 and 36 of the Health Insurance (Jersey) Law 1967[1], orders as follows –

1        Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Jersey) Order 2002 amended

In the Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Jersey) Order 2002[2] –

(a)     for Article 9(5) there shall be substituted the following paragraph –

“(5)    The circumstances referred to in paragraph (4) are where an approved supplier supplies by way of pharmaceutical benefit a substance or product in accordance with a prescription signed by an approved medical practitioner that specifies that it is to be supplied in instalments at stipulated intervals or on given dates and, at the time of supply, the substance or product is specified in Part 1, 2 or 3 of Schedule 2 to the Misuse of Drugs (Jersey) Law 1978[3].”;

(b)     for Schedule 4 there shall be substituted the following Schedule –

Name of drug and form

 

 

 

A. Anticonvulsants

 

 

 

Acetazolamide

Tablets 250 mg

 

 

Carbamazepine

Tablets 100 mg; 200 mg; 400 mg

 

Tablets M.R. 200 mg; 400 mg

 

Oral liquid 100 mg per 5 ml

 

 

Clobazam

Tablets 10 mg

 

 

Clonazepam

Tablets 0.5 mg; 2 mg

 

 

Ethosuximide

Capsules 250 mg

 

Oral liquid 250 mg per 5 ml

 

 

Lamotrigine

Tablets 25 mg; 50 mg; 100 mg; 200 mg

 

Dispersible Tablets 2 mg; 5 mg; 25 mg; 100 mg

 

 

Levetiracetam

Tablet 250 mg; 500 mg; 750 mg;

 

Oral solution 500 mg/5 ml

 

 

Phenobarbitone

Tablets 15 mg; 30 mg; 60 mg

 

Oral solution15 mg/5 ml

 

 

Phenytoin

Capsules 25 mg; 50 mg; 100 mg; 300 mg

 

Infatabs 50 mg

 

Suspension 30 mg per 5 ml

 

 

Primidone

Tablets 250 mg

 

 

Sodium Valproate

Syrup 200 mg per 5 ml;

 

Tablets enteric coated 200 mg; 500 mg

 

Tablets and Crushable 100 mg

 

Tablets M.R. 200 mg; 300 mg; 500 mg

 

Sugar free liquid 200 mg/5 ml

 

Capsules M.R. 150 mg; 300 mg

 

Granules 500 mg/sachet, 1 g/sachet

 

 

Topiramate

Tablets 25 mg; 50 mg; 100 mg; 200 mg

 

Capsules 50 mg

 

Sprinkle capsules 15 mg; 25 mg; 50 mg

 

B. Preparations for the management of diabetes

 

 

Acarbose

Tablets 50 mg; 100 mg

 

 

Canagliflozin

Tablets 100 mg; 300 mg

 

 

Clinitest

Tablets

 

 

Dapagliflozin

Tablets 5 mg; 10 mg

 

 

Empagliflozin

Tablets 10 mg; 25 mg

 

 

Exenatide

Injection 250 mcg/ml; 2 mg

 

 

Glibenclamide

Tablets 2.5 mg; 5 mg

 

 

Gliclazide

Tablets 80 mg

 

 

Insulin preparations

All insulins

 

 

Linagliptin

Tablets 5 mg

 

 

Liraglutide

Injection 6 mg/ml

 

 

Liraglutide/degludec

Injection 3.6 mg/100 IU

 

 

Metformin

Tablets 500 mg; 850 mg

 

Tablets M.R. 500 mg; 750 mg; 1g

 

Oral powder 500 mg/sachet; 1 g/sachet

 

 

Metformin/canagliflozin

Tablets 850 mg/50 mg; 1 g/50 mg

 

 

Metformin/dapagliflozin

Tablets 850 mg/5 mg/1g/5 mg

 

 

Metformin/linagliptin

Tablets 850 mg/2.5 mg; 1 g/2.5 mg

 

 

Metformin/pioglitazone

Tablets 850 mg/15 mg

 

 

Metformin/empagliflozin

Tablets 1g/5 mg, 1g/12.5 mg; 85 0mg/5 mg; 850 mg/12.5 mg

 

 

Pioglitazone

Tablets 15 mg; 30 mg; 45 mg

 

 

Saxagliptin

Tablets 2.5 mg; 5 mg

 

 

Sitagliptin

Tablets 25 mg; 50 mg; 100 mg

 

 

Sitagliptin/Metformin

Tablets 50 mg/1000 mg

 

 

Tolbutamide

Tablets 500 mg

 

 

Vildagliptin

Tablets 50 mg

 

 

Vildagliptin/Metformin

Tablets 50 mg/850 mg; 50 mg/1000 mg

 

C. Thyroid and antithyroid drugs

 

 

Carbimazole

Tablets 5 mg; 20 mg

 

 

Liothyronine Sodium

Tablets 20 mcg

 

 

Levothyroxine Sodium

Tablets 25 mcg; 50 mcg; 75 mcg; 100 mcg

 

Oral or transdermal medicine used for contraception and containing any of the following –

Co-cyprindiol

desogestrel

dienogest

drospirenone

estradiol hemihydrate

estradiol valerate

ethinylestradiol

gestodene

levonorgestel

mestranol

nomegestrol

norelgestromin

norgestimate

norethisterone

 

Oral, vaginal or transdermal medicines containing the following female sex hormones when used as hormone replacement therapy –

Conjugated oestrogens

Estradiol

Ethinylestradiol

Tibolone”.

2        Citation and commencement

This Order may be cited as the Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Amendment No. 14) (Jersey) Order 2017 and shall come into force 7 days after it is made.

DEPUTY S.J. PINEL OF ST. CLEMENT

Minister for Social Security

 

 


 



[1]                                    chapter 26.500

[2]                                    chapter 26.500.22

[3]                                    chapter 08.680


Page Last Updated: 12 Oct 2017